PRF Technologies Ltd. (PRFX)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 17,000
- Net income
- -5,022,000
- Operating income
- -5,122,000
- Earnings per share
- -7.47
- R&D expense
- 1,136,000
Growth and profitability
- Operating margin
- -30,129.41
- Net margin
- -29,541.18
- Return on equity
- -58.78
- Return on assets
- -41.86
- Free cash flow margin
- -23,276.47
Balance sheet
- Total assets
- 11,998,000
- Total liabilities
- 2,708,000
- Shareholders' equity
- 8,543,000
- Cash and equivalents
- 3,125,000
- Current ratio
- 1.78
Cash flow and ratios
- Operating cash flow
- -3,955,000
- Free cash flow
- -3,957,000
Shareholder returns
- Shares outstanding
- 830,613
- Book value per share
- 10.29
Company information
- Headquarters
- Tel Aviv
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
PRF Technologies Ltd. trades on NASDAQ under the ticker symbol PRFX. This page brings together its price chart, company profile, key financial figures and technical indicators.